Search Results - Maryia Zhdanava
- Showing 1 - 4 results of 4
-
1
Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA by Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Patrick Lefebvre, Steven R. Feldman
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States by Lisa Harding, Kruti Joshi, Maryia Zhdanava, Aditi Shah, Arthur Voegel, Cindy Chen, Dominic Pilon
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA by Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, Annalise Hilts, Patrick Lefebvre, Steven R. Feldman
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States by Maryia Zhdanava, Timothy Fitzgerald, Dominic Pilon, Rachel E. Teneralli, Aditi Shah, Lilian Diaz, Patrick Lefebvre, Steven R. Feldman
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book